drug comparison, Sleep Health

Provigil vs Sunosi (solriamfetol) for daytime sleepiness

Provigil is the 1998 veteran: modafinil, a once-a-morning pill with more than 25 years of real-world use, cheap generics, and a long list of drug interactions.

Sunosi is the 2019 newer option: solriamfetol, a dopamine and norepinephrine reuptake inhibitor that leaves the liver almost alone, leaves the body through the kidneys, and asks for a blood pressure check before you start.

The bottom line on Provigil vs Sunosi: both are Schedule IV wakefulness medicines for excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea (OSA), and no trial has ever tested them head to head. Which one fits you usually depends less on “which is stronger” and more on your other health issues: birth control, blood pressure, kidney function, anxiety, and the other medicines you take. This guide is organized around those questions.

Short answer: Indirect comparisons suggest Sunosi may produce somewhat larger gains in wakefulness scores than modafinil in OSA, but the evidence is not head to head. Provigil (modafinil) weakens hormonal birth control and interacts with many drugs; Sunosi does not appear to, but it can raise blood pressure and needs lower doses in kidney disease. Your prescriber weighs these trade-offs with you.

Provigil vs Sunosi at a glance: the spec sheet

Before getting to patient questions, here are the basic facts side by side. Doses come from each drug’s FDA label and are shared as general information only. Your prescriber decides your actual dose.

FeatureProvigil (modafinil)Sunosi (solriamfetol)
Generic nameModafinilSolriamfetol
Brand makerTeva (originally Cephalon)Axsome Therapeutics (originally developed by Jazz)
First US approval19982019
How it worksWakefulness-promoting agent; exact mechanism not fully known, but it raises dopamine signaling in the brainDopamine and norepinephrine reuptake inhibitor (DNRI)
Approved uses (adults)Excessive sleepiness from narcolepsy, OSA, or shift work disorderExcessive daytime sleepiness from narcolepsy or OSA
DEA scheduleSchedule IVSchedule IV
How oftenOnce dailyOnce daily on waking; avoid within 9 hours of bedtime
Label doses (general info)200 mg in the morning for narcolepsy or OSA; 200 mg about 1 hour before a shift for shift work disorderNarcolepsy: starts 75 mg, range 75 to 150 mg. OSA: starts 37.5 mg, range 37.5 to 150 mg. Maximum 150 mg/day
OnsetPeak blood levels in 2 to 4 hoursAbsorbed quickly; peak within a few hours
Half-lifeAbout 15 hoursAbout 7 hours (longer in kidney disease)
Metabolism and excretionAbout 90% broken down in the liver; metabolites leave in urineBarely metabolized; about 95% leaves unchanged in urine
Hormonal birth controlCan make it less effective, during use and for 1 month after stoppingNo labeled interaction; not a CYP3A4 inducer in lab testing
Main warningsSerious rash (SJS, TEN, DRESS), angioedema, psychiatric symptoms, certain heart conditionsBlood pressure and heart rate increases, psychiatric symptoms; contraindicated with MAOIs
Generic available?Yes, widelyNo widely available generic in the US; ask your pharmacist

Two things jump out in this Provigil vs Sunosi spec sheet. First, modafinil has an extra approved use, shift work disorder. Second, the drugs leave the body by completely different routes, which drives many of the differences below. If you are comparing Provigil with its close cousin instead, see our guide to Nuvigil vs Provigil.

“Which keeps me more awake?” Sunosi vs modafinil, which is stronger

This is the most common Provigil vs Sunosi question, and the honest answer is that nobody knows for sure. No randomized trial has put modafinil and solriamfetol in the same study. What exists are separate placebo-controlled trials for each drug, plus statistical reviews that try to compare them indirectly.

What the Sunosi trials showed

Sunosi’s 12-week approval trials (the TONES program) measured two things: the Maintenance of Wakefulness Test (MWT), which times how long you can stay awake in a dim room, and the Epworth Sleepiness Scale (ESS), a 0 to 24 questionnaire about dozing off in daily life. In narcolepsy, the 150 mg dose added about 7.7 minutes on the MWT and lowered the ESS by about 3.8 points more than placebo, according to the label. The 75 mg dose showed a trend that did not reach statistical significance.

In OSA, results were stronger and showed a clear dose effect. Compared with placebo, the label reports MWT gains of roughly 4.5 minutes at 37.5 mg, 8.9 minutes at 75 mg, and 10.7 minutes at 150 mg. Withdrawal studies also showed sleepiness came back when people switched to placebo, which suggests the benefit holds over time.

What the indirect comparisons suggest

Researchers have tried to rank these drugs by pooling trials. An indirect treatment comparison by Ronnebaum and colleagues (2021) looked at solriamfetol, modafinil, and armodafinil in OSA and found larger estimated MWT and ESS improvements with solriamfetol at higher doses. That analysis was funded by the drug’s developer, which is worth keeping in mind. A broader network meta-analysis by Pitre and colleagues (2023) of medicines for sleepiness in OSA likewise placed solriamfetol among the most effective options, with modafinil and armodafinil also clearly better than placebo.

Here is the catch for anyone weighing modafinil vs solriamfetol. Indirect comparisons mix trials with different patients, different years, and different study designs. A difference of a few minutes on the MWT across separate studies is not the same as proof from a single trial. For narcolepsy, the American Academy of Sleep Medicine’s 2021 guideline recommends both modafinil and solriamfetol, without ranking one as the clear winner.

In practice, “stronger” also depends on you. Some people get excellent results from modafinil and never need anything else. Others find it wears off or barely helps. Sunosi gives prescribers a different mechanism to try. For more on modafinil specifically in OSA, see our upcoming guide to Provigil for sleep apnea.

Tip for OSA patients: Neither drug treats the blocked airway. Both labels say to keep using CPAP or your other primary OSA treatment. A wakefulness pill on top of skipped CPAP nights is a band-aid, not a fix.

“I take birth control”: solriamfetol and birth control vs modafinil

This is one of the clearest dividing lines in the Provigil vs Sunosi comparison. Modafinil speeds up a liver enzyme called CYP3A4, which also breaks down the hormones in many birth control methods. The Provigil label warns that steroidal contraceptives, such as pills containing ethinyl estradiol, may work less well. It advises a backup or alternative method during treatment and for one month after the last dose.

That warning reaches beyond the pill. Many hormonal patches, rings, and implants are also processed through the same enzyme, so ask your prescriber or pharmacist about your specific method. Non-hormonal options like a copper IUD are not affected by this enzyme effect.

Solriamfetol takes a different path. Its label says it is barely metabolized at all, and lab testing found it does not induce CYP3A4 at relevant concentrations. Because of that, the Sunosi label does not list a birth control interaction, and none is expected. That is based on how the drug is handled in the body, not on a dedicated contraceptive study, so it is still worth confirming with your care team.

Pregnancy is a separate question. Neither drug has enough human data to call it safe in pregnancy, and both companies run pregnancy exposure registries. If you are planning a pregnancy, talk with your prescriber before you conceive, not after. Solriamfetol does pass into breast milk, according to its label.

“I have high blood pressure or heart disease”: Sunosi blood pressure vs Provigil cautions

Here the Provigil vs Sunosi picture flips. Sunosi carries a specific label warning about dose-related increases in blood pressure and heart rate. The label tells prescribers to check and control high blood pressure before starting, and to monitor it regularly during treatment. It also advises extra caution for people with heart disease, existing high blood pressure, or older age.

How big are the changes? In the label’s trial data at 150 mg, average peak increases in narcolepsy were about 5 mmHg systolic and 4 mmHg diastolic, with heart rate up about 5 beats per minute, compared with smaller rises on placebo. In OSA, the average increases were smaller. That sounds modest, but averages hide individuals, and a few points of sustained pressure matters for someone already at risk.

Provigil is not a free pass either. Its label says it is not recommended for people with left ventricular hypertrophy, or for people with mitral valve prolapse who had symptoms on stimulants before. It suggests closer monitoring after a recent heart attack or unstable angina, and blood pressure and heart rate checks may be appropriate. Our comparison of Provigil vs Adderall covers how modafinil’s heart effects stack up against a classic stimulant.

Many people with OSA also have high blood pressure, since the two conditions often travel together. That makes this question very practical. If your pressure runs high, steady habits help no matter which drug you take; our guide to natural ways to lower blood pressure is a good starting point, alongside any medicine your doctor prescribes.

Call 911 if you have chest pain, fainting, a racing or pounding heartbeat with shortness of breath, sudden severe headache, or signs of stroke (face drooping, arm weakness, trouble speaking) while taking either medicine. With Provigil, also get emergency help for a spreading rash, blisters, peeling skin, mouth sores, or swelling of the face, lips, or throat.

“I have kidney disease”: Sunosi kidney dosing

Because about 95% of solriamfetol leaves the body unchanged in urine, kidney function controls how long it stays around. In moderate kidney disease, the half-life roughly doubles; in severe disease, it is close to four times longer, according to the label. That is why Sunosi has a kidney-based dosing chart.

Kidney function (eGFR)Sunosi label guidance (general info)
Mild (60 to 89)No dose adjustment
Moderate (30 to 59)Start 37.5 mg; may go up to 75 mg maximum after at least 7 days
Severe (15 to 29)37.5 mg maximum
End-stage kidney disease (under 15)Not recommended

On kidneys, Provigil vs Sunosi is a real difference. Modafinil is mostly cleared by the liver, so its label does not have the same kidney dosing chart. Instead, it calls for half the usual dose in severe liver impairment. Put simply: kidney problems tilt the scale away from Sunosi, while serious liver problems call for caution with Provigil. Either way, your prescriber should know your latest lab results before choosing.

“I have anxiety or insomnia”

On anxiety, Provigil vs Sunosi is closer to a tie. Both drugs can stir up anxiety and trouble sleeping. In Provigil’s trials, anxiety showed up in 5% of people versus 1% on placebo, nervousness in 7%, and insomnia in 5%. Headache and anxiety rose with dose. In Sunosi’s narcolepsy trials, anxiety affected 6% versus 1% on placebo, and the label lists anxiety, insomnia, and irritability under its psychiatric warnings.

Timing matters a lot here. Sunosi’s half-life is shorter, about 7 hours, but the label still says to avoid taking it within 9 hours of bedtime. Modafinil lasts longer, with a half-life near 15 hours, which is one reason a late dose can wreck a night; our explainer on how long Provigil lasts goes into detail. If sleep is already fragile, building better nighttime habits helps, and our guide on how to cure insomnia lists practical steps.

Both labels also ask for caution in people with a history of psychosis, bipolar disorder, or mania. Provigil’s label notes rare reports of mania, hallucinations, and suicidal thoughts. Sunosi was not studied in people with psychosis or bipolar disorder. If anxiety is part of your daily life, mention it before starting either drug, and see our guide on how to get rid of anxiety for non-drug strategies.

An illustrative example

Consider Dana, a made-up 41-year-old accountant with OSA who uses CPAP but still nods off at her desk. She also has generalized anxiety. Her prescriber might start low with either drug, ask her to log both sleepiness and jitteriness for a few weeks, and adjust from there. This is an illustration only, not a recommendation for anyone’s care.

“I’m on an MAOI”

This one is simple on the Sunosi side: it is contraindicated. The label says not to take Sunosi with a monoamine oxidase inhibitor (MAOI), or within 14 days after stopping one, because the combination can cause a dangerous spike in blood pressure. MAOIs include certain older antidepressants like phenelzine and tranylcypromine, the Parkinson’s drugs selegiline and rasagiline, and the antibiotic linezolid.

Provigil’s label is softer, advising caution when used with MAOIs rather than an outright ban. That does not mean the pairing is risk-free; it means the decision rests with your prescriber. Both drugs also call for care with other medicines that raise blood pressure or affect dopamine. Modafinil adds a long list of liver-enzyme interactions, including warfarin, cyclosporine, some seizure medicines, and certain anti-anxiety drugs.

Bring a full list of everything you take, including supplements and over-the-counter cold medicines with decongestants. A pharmacist can run an interaction check in minutes.

“I tried one and it didn’t work”

Because Provigil and Sunosi work in different ways, a poor response to one does not predict a poor response to the other. Modafinil’s exact mechanism is still not fully mapped, while solriamfetol directly blocks the reuptake of both dopamine and norepinephrine. Some people who felt little from modafinil respond well to Sunosi, and the reverse also happens.

Before blaming the drug, a prescriber will usually look at other causes of lingering sleepiness. Common ones include CPAP that leaks or isn’t used most nights, too little total sleep, sedating medicines, depression, low thyroid, or a second sleep disorder. Reading up on the importance of sleep for health is a useful reminder that no pill replaces enough hours in bed.

If you have narcolepsy, there are more options beyond these two. Pitolisant (Wakix) works on histamine and is not a controlled substance; our upcoming comparison of Provigil vs Wakix covers it. Our Provigil for narcolepsy hub explains where modafinil fits in the wider treatment plan, including for cataplexy, which neither Provigil nor Sunosi is approved to treat.

Sunosi side effects vs Provigil side effects

The table below lists common side effects from each drug’s placebo-controlled trials, as reported in the FDA labels. Because the studies were separate, with different patients and designs, use the numbers to get a feel for each drug’s profile rather than to rank them.

Side effectProvigil (vs placebo)Sunosi, narcolepsy (vs placebo)Sunosi, OSA (vs placebo)
Headache34% (23%)16% (7%)Not listed at 2% or more above placebo
Nausea11% (3%)7% (4%)8% (6%)
Decreased appetiteNot among top reactions9% (1%)6% (1%)
Anxiety5% (1%)6% (1%)4% (1%)
Nervousness / irritabilityNervousness 7% (3%)Not listedIrritability 3% (0%)
Insomnia5% (1%)5% (4%)Not listed
Diarrhea6% (5%)Not listed4% (1%)
Dry mouthNot among top reactions4% (2%)3% (2%)
PalpitationsNot among top reactions2% (1%)3% (0%)
Dizziness5% (4%)Not listedNot listed
Stopped due to side effects8% (3%)3% (under 1%)

A few patterns stand out when you line up Sunosi vs Provigil side effects. Headache is the signature complaint with modafinil. Sunosi’s list leans toward appetite loss, dry mouth, and palpitations, which fits a drug that boosts norepinephrine. The rare but serious risks also differ: Provigil carries the skin-reaction warning (SJS, TEN, DRESS), while Sunosi’s main serious concern is blood pressure.

Safety basics for both: Take the medicine exactly as prescribed and never share it, since both are controlled substances. Store it locked up, away from children and visitors. Drop unused tablets at a pharmacy or DEA take-back site. Do not stop or change your dose on your own; call your prescriber first.

What’s next for Sunosi: research, not approvals

You may see headlines about Sunosi for other conditions. As of Axsome’s August 10, 2026 business update, its only approved uses remain sleepiness from narcolepsy and OSA. The company is running Phase 3 trials of solriamfetol in several new areas:

  • ADHD: the FOCUS-3 trial in adolescents and FOCUS-2 in children began in mid-2026.
  • Major depressive disorder with excessive daytime sleepiness: the CLARITY trial.
  • Binge eating disorder: the ENGAGE trial, with topline results expected in late 2026.
  • Shift work disorder: the SUSTAIN trial, with results expected in 2027.

None of these uses is FDA-approved. Ongoing trials can fail, and results can take years to turn into label changes. For now, if you have shift work disorder, modafinil is the one of these two with that approval.

Switching from Provigil to Sunosi (or back)

Switching from Provigil to Sunosi is a prescriber-led process, not something to do on your own with leftover pills. There is no official conversion chart, because the two drugs act differently and their doses are not equivalent. Instead, prescribers generally restart the new drug at its label starting dose and adjust over time.

Here is what a switch often involves, in general terms:

  1. A baseline check. Blood pressure and heart rate before Sunosi, plus kidney function if there is any doubt.
  2. A medication review. Ruling out MAOIs and flagging drugs that raise blood pressure. If modafinil had been affecting other drug levels, those may shift after it stops.
  3. A birth control plan. The Provigil label calls for backup contraception for one month after the last modafinil dose, even after switching.
  4. Slow steps. The Sunosi label allows doses to be doubled at intervals of at least 3 days, up to the maximum, based on response and tolerance. Your prescriber sets the pace.
  5. Follow-up. A check-in on sleepiness scores, sleep quality, mood, and blood pressure after a few weeks.

Going the other way, from Sunosi to Provigil, brings its own checklist: the contraceptive interaction kicks in, and liver-enzyme interactions with your other medicines return. Either direction, tell your prescriber about any rash, mood change, or chest symptoms right away.

Provigil vs Sunosi: frequently asked questions

Is Sunosi stronger than modafinil?

Possibly in OSA, but it is not proven. Indirect comparisons that pool separate trials suggest solriamfetol at higher doses may improve wakefulness scores somewhat more than modafinil. No head-to-head trial exists, and individual response varies widely. Some people do better on modafinil. Your prescriber can help you judge based on how you respond, not on rankings alone.

Does Sunosi raise blood pressure more than Provigil?

Sunosi has a specific label warning for dose-related rises in blood pressure and heart rate, and prescribers are told to check and control pressure before starting. Provigil’s label also suggests monitoring and caution with heart disease, but without the same dedicated warning. If you have high blood pressure, expect closer monitoring with Sunosi and discuss your heart history either way.

Can I take Sunosi if I use the birth control pill?

The Sunosi label lists no interaction with hormonal birth control, and lab data show it does not speed up the liver enzyme that breaks down contraceptive hormones. Modafinil, by contrast, can make birth control less reliable during treatment and for a month afterward. Still, confirm your specific method with your prescriber or pharmacist before relying on it.

Is Sunosi safe with kidney disease?

It can be used with mild to severe kidney disease at adjusted doses, but it is not recommended for end-stage kidney disease (eGFR under 15). Because nearly all of the drug leaves through the kidneys, it builds up when they work poorly. The label lowers the maximum dose for moderate and severe impairment. Your prescriber will check recent kidney labs first.

Is Sunosi a stimulant like Adderall?

Not exactly. Sunosi blocks dopamine and norepinephrine reuptake, but it does not push the brain to release these chemicals the way amphetamines do. It is Schedule IV, a lower control level than Schedule II stimulants like Adderall. Like modafinil, it still carries some potential for misuse, so it should never be shared or taken in higher doses than prescribed.

Can Sunosi be used for shift work disorder?

Not as an approved use. Sunosi is approved only for daytime sleepiness from narcolepsy or OSA. Axsome is testing it for shift work disorder in a Phase 3 trial called SUSTAIN, with results expected in 2027. Modafinil (Provigil) is the one of the two currently approved for shift work disorder. Any use outside the label is a prescriber’s call.

How long after my last Provigil dose can I start Sunosi?

There is no official waiting period on either label, and switching plans are individual. Prescribers consider modafinil’s roughly 15-hour half-life, your blood pressure, and your other medicines. Some switch the next morning; others pause. Remember that the birth control interaction from modafinil lasts about a month after stopping. Follow your prescriber’s specific plan rather than timing it yourself.

The takeaway on Provigil vs Sunosi

Provigil vs Sunosi is less a contest of strength than a question of fit. Modafinil offers a long track record, generic availability, and a shift work disorder approval, but it weakens hormonal birth control and interacts with many drugs. Sunosi offers a different mechanism, few metabolic drug interactions, and possibly larger wakefulness gains in OSA, but it raises blood pressure, is off-limits with MAOIs, and needs lower doses in kidney disease. Bring your health history, your medication list, and your contraceptive plan to the conversation, and let your prescriber guide the choice.

This article is for education only and is not medical advice. Do not start, stop, or change any medicine without talking to your prescriber. Provigil (modafinil) and Sunosi (solriamfetol) are Schedule IV controlled substances that should only be used with a valid prescription, exactly as directed, and never shared. If someone has chest pain, fainting, a seizure, or a severe skin reaction, call 911 right away.

Sources

Leave a Reply

Your email address will not be published. Required fields are marked *